🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,032 results for “United Therapeutics Europe Ltd” Clear

  1. PVSRIPO

    United Therapeutics Europe Ltd

    Invasive Breast Cancer

    phase 1 mab completed

    1 trial
  2. Palbociclib + Taselisib / Pictilisib

    United Therapeutics Europe Ltd

    Advanced Solid Tumours

    phase 1 small molecule completed

    1 trial
  3. Pembrolizumab

    United Therapeutics Europe Ltd

    Thoracic Tumours

    phase 1 small molecule completed

    1 trial
  4. Pembrolizumab

    United Therapeutics Europe Ltd

    Cervix Cancer

    phase 1 other terminated

    1 trial
  5. Physical Activity Educational Materials

    United Therapeutics Europe Ltd

    Physical Inactivity

    phase 1 other completed

    1 trial
  6. Pitavastatin

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial
  7. Placebo Intravaginal Ring A

    United Therapeutics Europe Ltd

    Safety

    phase 1 other terminated

    1 trial
  8. Placebo Vaginal Film with Square Corners

    United Therapeutics Europe Ltd

    Safety

    phase 1 small molecule completed

    1 trial
  9. Plasmodium falciparum Malaria Protein 010 (FMP010)

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial
  10. Plerixafor

    United Therapeutics Europe Ltd

    Pancreatic Adenocarcinoma Metastatic

    phase 1 small molecule completed

    1 trial
  11. Pramipexole

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 1 small molecule completed

    1 trial
  12. Protexia

    United Therapeutics Europe Ltd

    Intervention for Nerve Agent Exposure

    phase 1 mab completed

    1 trial
  13. Provision of extra (care coordination and management) services

    United Therapeutics Europe Ltd

    Hospitalization

    phase 1 other completed

    1 trial
  14. Psilocybin

    United Therapeutics Europe Ltd

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule active

    1 trial
  15. Q-Griffithsin

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule completed

    1 trial
  16. Q-Griffithsin 3.0

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule active

    1 trial
  17. Rehabilitation

    United Therapeutics Europe Ltd

    Stroke

    phase 1 other completed

    1 trial
  18. SOM 230 / Pasireotide

    United Therapeutics Europe Ltd

    Atypical Ductal Breast Hyperplasia

    phase 1 small molecule completed

    1 trial
  19. Shigella sonnei 53G

    United Therapeutics Europe Ltd

    Healthy

    phase 1 mab completed

    1 trial
  20. Shigella sonnei 53G

    United Therapeutics Europe Ltd

    Shigellosis

    phase 1 mab active

    2 trials
  21. Simvastatin

    United Therapeutics Europe Ltd

    Recurrent Acute Pancreatitis

    phase 1 small molecule active

    1 trial
  22. TAF/EVG Vaginal Insert

    United Therapeutics Europe Ltd

    Hiv

    phase 1 small molecule completed

    1 trial
  23. TAF/EVG vaginal insert

    United Therapeutics Europe Ltd

    Safety Issues

    phase 1 small molecule completed

    1 trial
  24. Tepotinib

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources